Načítá se...

A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

BACKGROUND: Inflammatory Bowel Disease (IBD) patients post orthotopic liver transplantation (OLT) often have ongoing mucosal inflammation necessitating biologic agents for therapy. The safety of combined biologic and immunosuppressive therapy post-OLT in this population is unclear. AIMS: To systemat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Can Assoc Gastroenterol
Hlavní autoři: Al Draiweesh, S, Ma, C, Alkhattabi, M, Nguyen, T, Brahmania, M, Jairath, V
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512737/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.125
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!